Stocks · Health care · Biological Products, (No Diagnostic Substances)

Revolution Medicines, Inc.

RVMD Clue Score22
United States Fiscal year ends December CIK 0001628171 Results filed 4 Nov 2026

What the insiders did Mostly scheduled

Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$154.21M
$31.01M on a plan · $122.48M straight out of an exercise
Sold at will
$720.49K
1 of 159 sales
Net
−$154.21M
−$720.49K against sales at will